文献速递临床试验与 GCP

聚焦性子宫腺肌病保守手术后联合曲普瑞林与单纯手术复发对比的多中心随机对照试验方案

Relapse after conservative surgery combined with triptorelin acetate versus conservative surgery only in women with focal adenomyosis: study protocol for a multicenter, prospective, randomized controlled trial.
PubMed 文献 · Trials · 2020-04-28

本研究为多中心前瞻性随机对照试验,旨在比较聚焦性子宫腺肌病患者保守手术后联合醋酸曲普瑞林与单纯手术的复发情况。主要结局为通过VAS/NRS、PBAC评分及影像学测量的复发,次要结局包括生活质量、临床妊娠、卵巢储备等,于术后3至36个月随访。

要点

  • 比较保守手术后联合GnRHa与单纯手术的复发率。
  • 主要结局采用疼痛评分、出血评分及影像学测量。
  • 多中心随机设计为术后长期管理提供证据。

核心结论

  • 该试验旨在评估曲普瑞林减少聚焦性子宫腺肌病保守手术后复发的疗效。

研究设计与样本

  • 多中心、前瞻性、随机对照试验,注册号ChiCTR1800014340。

主要发现

  • 原文未报告结果。

关键数值与推荐

  • 主要结局为复发,采用VAS/NRS、PBAC评分及2D/3D-CDUS或MRI测量子宫和病灶大小评估。
  • 次要结局包括生活质量、临床妊娠、卵巢储备、不良事件、SF-36和FSFI评分、血清FSH、雌二醇及抗苗勒管激素等。
  • 所有指标在术后3、6、12、18、24、30和36个月测量。

临床怎么用

  • 若试验证实有效,可为聚焦性子宫腺肌病保守手术后长期管理提供GnRHa治疗策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The preservation of fertility and integrity of the reproductive organs has increasingly been of concern to most women with adenomyosis. Adenomyomectomy is conservative surgery that is now widely applied; however, relapse is a serious problem after the operation. Postoperative treatment, such as gonadotropin-releasing hormone agonist (GnRHa) has been suggested to result in reducing the rate of disease recurrence. However, there is still a lack of evidence from randomized clinical trials examining the efficacy of GnRHa in decreasing the postoperative recurrence rate. METHOD/DESIGN: Relapse after conservative surgery combined with triptorelin acetate versus conservative surgery only in women with focal adenomyosis is a multicenter, prospective, randomized controlled trial. The primary outcome is relapse assessed using a visual analogue scale (VRS) and numeric rating scale (NRS), pictorial blood loss assessment chart (PBAC) score, and the size of the uterus and the lesion as measured by two/three-dimensional color doppler ultrasonography (2D/3D-CDUS) or magnetic resonance imaging (MRI). The secondary outcomes include quality of life, clinical pregnancy, ovarian reserve, adverse events, assessment by the Short Form (36) Health Survey and Female Sexual Function index, serum follicle-stimulating hormone, estradiol levels, and anti-Muellerian hormone and so on. All these indexes are measured at 3, 6, 12, 18, 24, 30, and 36 months after conservative surgery. DISCUSSION: The result of this large, multicenter randomized trial will provide evidence for one of the strategies of long-term management in focal adenomyosis after conservative operation. TRIAL REGISTRATION: Chinese Clinical Trial Registry: ChiCTR1800014340. Registered on 6 January 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wang W, Ma X, Zhang W, et al. Relapse after conservative surgery combined with triptorelin acetate versus conservative surgery only in women with focal adenomyosis: study protocol for a multicenter, prospective, randomized controlled trial. Trials. 2020. PMID: 32345377. doi:10.1186/s13063-020-04294-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。